BMC Gastroenterology (Sep 2010)

African-American inflammatory bowel disease in a Southern U.S. health center

  • Veluswamy Hemanth,
  • Suryawala Kunal,
  • Sheth Ankur,
  • Wells Shannon,
  • Salvatierra Erik,
  • Cromer Walter,
  • Chaitanya Ganta V,
  • Painter Annette,
  • Patel Mihir,
  • Manas Kenneth,
  • Zwank Ellenmarie,
  • Boktor Moheb,
  • Baig Kondal,
  • Datti Balaji,
  • Mathis Michael J,
  • Minagar Alireza,
  • Jordan Paul A,
  • Alexander Jonathan S

DOI
https://doi.org/10.1186/1471-230X-10-104
Journal volume & issue
Vol. 10, no. 1
p. 104

Abstract

Read online

Abstract Background Inflammatory Bowel Diseases (IBD) remain significant health problems in the US and worldwide. IBD is most often associated with eastern European ancestry, and is less frequently reported in other populations of African origin e.g. African Americans ('AAs'). Whether AAs represent an important population with IBD in the US remains unclear since few studies have investigated IBD in communities with a majority representation of AA patients. The Louisiana State University Health Sciences Center in Shreveport (LSUHSC-S) is a tertiary care medical center, with a patient base composed of 58% AA and 39% Caucasian (W), ideal for evaluating racial (AA vs. W) as well and gender (M vs. F) influences on IBD. Methods In this retrospective study, we evaluated 951 visits to LSUHSC-S for IBD (between 2000 to 2008) using non-identified patient information based on ICD-9 medical record coding (Crohn's disease 'CD'-555.0- 555.9 and ulcerative colitis 'UC'-556.0-556.9). Results Overall, there were more cases of CD seen than UC. UC and CD affected similar ratios of AA and Caucasian males (M) and females (F) with a rank order of WF > WM > AAF > AAM. Interestingly, in CD, we found that annual visits per person was the highest in AA M (10.7 ± 1.7); significantly higher (* -p Conclusion Although Caucasians still represent the greatest fraction of IBD (~64%), AAs with IBD made up >1/3 (36.4%) of annual IBD cases from 2000-2008 at LSUHSC-S. Further studies on genetic and environments risks for IBD risk in AAs are needed to understand differences in presentation and progression in AAs and other 'non-traditional' populations.